FDA NDC
Skyrizi
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0074-8300
- Proprietary name
- Skyrizi
- Nonproprietary name
- risankizumab-rzaa
- Labeler
- AbbVie Inc.
- Dosage form
- INJECTION
- Strength
- 180 mg/1.2mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted risankizumab-rzaa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.